Clinton Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-10,476
Closed -$308K 921
2016
Q1
$308K Buy
+10,476
New +$308K 0.02% 736